ClinicalTrials.gg
CompletedNCT06275750Updated Feb 6, 2025

Non-surgical Spinal Decompression in Patients with Chronic Low Back Pain

An interventional study of Spinal decompression with BTL-6000 spinal decompression system (BTL Industries Ltd.) in Low Back Pain, Sciatica and Lumbar Disc Herniation, sponsored by Hospital Civil de Guadalajara. Completed at 1 site in Mexico. Open to participants aged 18 Years to 55 Years. Per ClinicalTrials.gov, last updated 2025-02-06.

Sponsored by Hospital Civil de Guadalajara · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 5 months after the study started (first participant enrolled Aug 2023, registered Feb 2024).
Phase
Not applicable
Study type
Interventional
Enrollment
39
Allocation
Not applicable
Ages
18 Years to 55 Years
Sex
All
01

Study summary

The goal of this quasi-experimental trial was to evaluate the effects of non-surgical spinal decompression on disability and pain in patients with chronic low back pain and sciatica throughout a two-month follow-up, and to analyze the relationship between demographic factors and clinical outcomes after a program of non-surgical spinal decompression.

The main questions it aims to answer were:

  • Non-surgical spinal decompression is effective to reduce pain intensity and self-reported disability in patients with chronic low back pain and sciatica?
  • Age, level of education and work activities are related with clinical outcome in patients treated with non-surgical spinal decompression?

Participants underwent eight sessions, three per week, with the BTL-6000 spinal decompression system. The study did not have a comparison group.

02

Conditions studied

  • Low Back Pain
  • Sciatica
  • Lumbar Disc Herniation
03

In context

Low Back Pain

2,922 studies on the registry are indexed under Low Back Pain; 580 are open to participants now.

This study's enrollment of 39 is below the median of 60 across 2,364 interventional studies indexed under Low Back Pain.

Browse Low Back Pain studies →

Lead sponsor

Hospital Civil de Guadalajara is the lead sponsor of 41 studies on the registry; 11 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 55 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age between 18 and 55 years old.
  • Chronic (at least six months) low back pain (LBP) and/or sciatica.
  • Abnormalities of intervertebral disc on magnetic resonance imaging (MRI).

Exclusion criteria

Exclusion Criteria:

  • Patients with prior spine surgery.
  • Vertebral instability.
  • Cancer.
  • Current infectious disease.
  • Pregnancy.
  • Kinesiophobia.
  • Fibromyalgia.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
39 participants (actual)

Study arms

  • Experimental
    Patients treated with non-surgical spinal decompression

    The patients were positioned in supine with adjustable lumbar, and thoracic belts attached to the traction cord. After tightening the belts, the M7 position was selected to achieve hip and knee flexion, and posterior pelvic tilt of 25° was added. Before starting the therapy, the weight of the subject was entered in the panel, and a short tolerance test was carried out. Patients were provided with a manual switch to stop treatment any time. Preset lumbar disc herniation protocol was used. Each session lasted fifteen minutes, applied force had 100-gram step increments, and did not exceed 50% of the weight of the patient. At the end of the therapy, the cord was disconnected and belts were removed. Participants were asked to sit for three minutes to identify any adverse reaction.

    Device: Spinal decompression with BTL-6000 spinal decompression system (BTL Industries Ltd.)

Interventions

  • DeviceSpinal decompression with BTL-6000 spinal decompression system (BTL Industries Ltd.)

    The patients were positioned in supine with adjustable lumbar, and thoracic belts attached to the traction cord. After tightening the belts, the M7 position was selected to achieve hip and knee flexion, and posterior pelvic tilt of 25° was added. Before starting the therapy, the weight of the subject was entered in the panel, and a short tolerance test was carried out. Patients were provided with a manual switch to stop treatment any time. Preset lumbar disc herniation protocol was used. Each session lasted fifteen minutes, applied force had 100-gram step increments, and did not exceed 50% of the weight of the patient. At the end of the therapy, the cord was disconnected and belts were removed. Participants were asked to sit for three minutes to identify any adverse reaction.

06

What researchers measure

Primary outcomes

  1. Self-reported disability

    We measured self-reported disability associated with spine disorders through the spanish version of the Oswestry Disability Index (ODI), a reliable and validated instrument composed by ten sections (pain intensity, personal care, lifting, walking, sitting, standing, sleeping, sex life, social life and traveling), in which the patient grades the disability from zero (no limitation) to five (limitation prevents me from performing the activity). The ODI final score was calculated with the following formula: \[total score/(5 x number of answered questions)\] x 100%, and interpreted as the higher the score, the greater the disability.

    Time frame: Baseline, at the end of the eighth session, and at 2nd-month follow-up.

  2. Pain intensity

    Pain intensity was also evaluated with the numeric pain rating scale (NPRS), a popular clinical tool consisting of a numbered straight line from zero (no pain) to ten (the worst pain), where the patients registered their current pain intensity.

    Time frame: Baseline, at the end of the eighth session, and at 2nd-month follow-up.

07

Study locations

1 site
  • Hospital Civil de Guadalajara Fray Antonio Alcalde
    Guadalajara, Jalisco 44280, Mexico
08

References and documents

Individual participant data

Plan to share: Yes — The data that support the findings of this study are available from the corresponding author, upon reasonable request.

Supporting information: Study protocol, Statistical analysis plan, Informed consent form

Time frame: No determined.

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Aug 2023 to primary completion in Nov 2023, 3 months.

Of 1,231 non-industry interventional studies with no phase under Low Back Pain, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 26. This study's 3 months is below that.

Counting every sponsor, half of 1,286 studies reached it within 11 months; a quarter within 5 and three quarters within 27.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 9, 2024
First posted
Feb 23, 2024
StartActual
Aug 21, 2023
Primary completionActual
Nov 29, 2023
CompletionActual
Jan 11, 2024
Last update
Feb 6, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Feb 6, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06275750
Lead sponsor
Hospital Civil de Guadalajara
Responsible party
Armando Tonatiuh Avila Garcia (Chief Department of Physical Medicine and Rehabilitation, Hospital Civil de Guadalajara) — Principal investigator
First posted
Feb 23, 2024
Start date
Aug 21, 2023
Primary completion
Nov 29, 2023
Completion
Jan 11, 2024
Last update
Feb 6, 2025

Study contacts

Tonatiuh Avila, MD
principal investigator · Hospital Civil de Guadalajara

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion